MBOT
MBOT
NASDAQ · Health Care

Microbot Medical Inc

$1.89
+0.09 (+5.00%)
As of Aug 15, 2:15 AM ET ·
Financial Highlights (FY 2026)
Revenue
1.53B
Net Income
-17,338,470
Gross Margin
82.8%
Profit Margin
-3,241.6%
Rev Growth
-6.1%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 82.8% 82.8% 62.2% 62.2%
Operating Margin -3,302.0% -2,971.8% 25.4% 22.6%
Profit Margin -3,241.6% -3,079.5% 17.2% 19.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.53B 1.62B 39.93M 46.94M
Gross Profit 1.26B 1.34B 24.82M 29.18M
Operating Income -50,369,159,271 -48,277,149,461 10.16M 10.59M
Net Income -17,338,470 -16,618,341 6.88M 9.06M
Gross Margin 82.8% 82.8% 62.2% 62.2%
Operating Margin -3,302.0% -2,971.8% 25.4% 22.6%
Profit Margin -3,241.6% -3,079.5% 17.2% 19.3%
Rev Growth -6.1% -6.1% -1.2% +14.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 23.03M 24.03M
Total Equity 67.54M 68.59M
D/E Ratio 0.34 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -18,975,656 -19,197,948 11.85M 15.12M
Free Cash Flow 3.52M 6.34M